Rxo (RXO) Invested Capital (2021 - 2025)
Historic Invested Capital for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $1.9 billion.
- Rxo's Invested Capital fell 176.77% to $1.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 billion, marking a year-over-year decrease of 176.77%. This contributed to the annual value of $1.9 billion for FY2025, which is 176.77% down from last year.
- Per Rxo's latest filing, its Invested Capital stood at $1.9 billion for Q4 2025, which was down 176.77% from $2.0 billion recorded in Q3 2025.
- In the past 5 years, Rxo's Invested Capital registered a high of $2.0 billion during Q3 2024, and its lowest value of $949.0 million during Q1 2024.
- Moreover, its 5-year median value for Invested Capital was $1.1 billion (2021), whereas its average is $1.4 billion.
- As far as peak fluctuations go, Rxo's Invested Capital crashed by 913.84% in 2023, and later surged by 10979.98% in 2025.
- Over the past 5 years, Rxo's Invested Capital (Quarter) stood at $1.1 billion in 2021, then decreased by 2.62% to $1.0 billion in 2022, then decreased by 8.54% to $953.0 million in 2023, then surged by 107.76% to $2.0 billion in 2024, then decreased by 1.77% to $1.9 billion in 2025.
- Its Invested Capital was $1.9 billion in Q4 2025, compared to $2.0 billion in Q3 2025 and $2.0 billion in Q2 2025.